Literature DB >> 10473219

Penicillin-resistant Streptococcus pneumoniae: selection by both beta-lactam and non-beta-lactam antibiotics.

F W Goldstein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10473219     DOI： 10.1093/jac/44.2.141

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  Impact of Antimicrobial Resistance on the Treatment of Invasive Pneumococcal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

2.  In vitro activities of tigecycline (GAR-936) against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae.

Authors:  M D Kitzis; A Ly; F W Goldstein
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 3.  Origin and proliferation of multiple-drug resistance in bacterial pathogens.

Authors:  Hsiao-Han Chang; Ted Cohen; Yonatan H Grad; William P Hanage; Thomas F O'Brien; Marc Lipsitch
Journal:  Microbiol Mol Biol Rev       Date:  2015-03       Impact factor: 11.056

Review 4.  Silver nanoparticles as antimicrobial therapeutics: current perspectives and future challenges.

Authors:  Parteek Prasher; Manjeet Singh; Harish Mudila
Journal:  3 Biotech       Date:  2018-09-14       Impact factor: 2.406

5.  Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.

Authors:  Penny Crowther-Gibson; Cheryl Cohen; Keith P Klugman; Linda de Gouveia; Anne von Gottberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

6.  Potent oxazolidinone antibacterials with heteroaromatic C-ring substructure.

Authors:  Hideyuki Suzuki; Iwao Utsunomiya; Koichi Shudo; Takaji Fujimura; Masakatsu Tsuji; Issei Kato; Toshiaki Aoki; Akira Ino; Tsutomu Iwaki
Journal:  ACS Med Chem Lett       Date:  2013-09-22       Impact factor: 4.345

7.  Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae.

Authors:  César García-Rey; Lorenzo Aguilar; Fernando Baquero; Julio Casal; Rafael Dal-Ré
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 8.  Clinical role of beta-lactam/beta-lactamase inhibitor combinations.

Authors:  Nelson Lee; Kwok-Yung Yuen; Cyrus R Kumana
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Telithromycin-resistant Streptococcus pneumoniae.

Authors:  Fred Goldstein; Barbara Vidal; Marie D Kitzis
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

10.  Host population structure and treatment frequency maintain balancing selection on drug resistance.

Authors:  Sarah Cobey; Edward B Baskerville; Caroline Colijn; William Hanage; Christophe Fraser; Marc Lipsitch
Journal:  J R Soc Interface       Date:  2017-08       Impact factor: 4.118
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.